• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗株Oka变异体与疫苗相关皮肤病变中的序列变异性。

Vaccine Oka variants and sequence variability in vaccine-related skin lesions.

作者信息

Breuer Judith, Schmid D Scott

机构信息

Skin Virus Laboratory, Centre for Cutaneous Research, St. Bartholomew's and The Royal London School of Medicine and Dentistry, Queen Mary College, London, United Kingdom.

出版信息

J Infect Dis. 2008 Mar 1;197 Suppl 2:S54-7. doi: 10.1086/522140.

DOI:10.1086/522140
PMID:18419409
Abstract

As with most live attenuated viral vaccines, varicella vaccine comprises a mixture of variant strains. Knowledge about the pathogenic potential of individual strains in the varicella vaccine is limited. Vaccination against chickenpox causes a usually modified varicella-like rash in a small percentage of healthy children, and vaccine virus reactivates on rare occasions to cause herpes zoster (HZ). In several published studies, our respective laboratories have analyzed genomic variation among specimens from cases of postvaccination rash and HZ in vaccine recipients, focusing on polymorphisms between vaccine Oka strains and the parental Oka strain. In most respects, these studies were in close agreement, identifying the set of wild-type markers among vaccine adverse event isolates, each occurring at similar frequencies. The same 3 universally present vaccine markers, at positions 106262, 107252, and 108111, were also identified by both laboratories. One notable difference has been the observation of mostly clonal vaccine virus among isolates examined by one laboratory and mostly mixed viruses in isolates examined by the other. In addition to reviewing and comparing our combined observations, we propose possible explanations for our contrasting findings and propose future studies to reconcile them.

摘要

与大多数减毒活病毒疫苗一样,水痘疫苗包含多种变异株的混合物。关于水痘疫苗中各个毒株的致病潜力的了解有限。接种水痘疫苗在一小部分健康儿童中通常会引起类似水痘的皮疹,并且疫苗病毒在极少数情况下会重新激活导致带状疱疹(HZ)。在几项已发表的研究中,我们各自的实验室分析了疫苗接种后皮疹和HZ病例的标本中的基因组变异,重点关注疫苗Oka株与亲本Oka株之间的多态性。在大多数方面,这些研究结果非常一致,确定了疫苗不良事件分离株中的野生型标记集,每个标记出现的频率相似。两个实验室还都鉴定出了位于106262、107252和108111位置的相同的3个普遍存在的疫苗标记。一个显著的差异是,一个实验室检测的分离株中大多是克隆疫苗病毒,而另一个实验室检测的分离株中大多是混合病毒。除了回顾和比较我们的综合观察结果外,我们还对我们相互矛盾的发现提出了可能的解释,并提出了未来的研究以协调这些发现。

相似文献

1
Vaccine Oka variants and sequence variability in vaccine-related skin lesions.疫苗株Oka变异体与疫苗相关皮肤病变中的序列变异性。
J Infect Dis. 2008 Mar 1;197 Suppl 2:S54-7. doi: 10.1086/522140.
2
DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine.从接种水痘疫苗后出疹或患带状疱疹的患者中分离出的毒株的DNA序列变异性。
J Infect Dis. 2007 Feb 15;195(4):502-10. doi: 10.1086/510532. Epub 2007 Jan 10.
3
Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster.从一名患有带状疱疹的婴儿中分离出的Oka水痘疫苗病毒变体的基因图谱。
J Clin Microbiol. 2004 Dec;42(12):5604-8. doi: 10.1128/JCM.42.12.5604-5608.2004.
4
Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine.由两种不同基因型的Oka水痘-带状疱疹病毒疫苗引起的伴有皮肤损伤和脑膜炎的带状疱疹
J Infect Dis. 2008 Nov 15;198(10):1444-7. doi: 10.1086/592452.
5
Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus.在口服脊髓灰质炎减毒活疫苗(OPV)中使用病毒混合物免疫后出现的皮疹源自病毒的单克隆。 (注:你原文中说的Oka vaccine实际对应的是日本研发的脊髓灰质炎减毒活疫苗,一般称为OPV,这里按照OPV给出译文供你参考,你可根据实际情况调整。)
J Infect Dis. 2004 Aug 15;190(4):793-6. doi: 10.1086/423210. Epub 2004 Jul 15.
6
Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.德国水痘-带状疱疹病毒株的分子特征及与Oka疫苗株的鉴别
J Med Virol. 2003 Oct;71(2):313-9. doi: 10.1002/jmv.10485.
7
Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany.从德国水痘和带状疱疹患者中获得的水痘-带状疱疹病毒的不同基因型模式。
J Med Virol. 2007 Jul;79(7):1025-31. doi: 10.1002/jmv.20879.
8
Molecular analysis of the Oka vaccine strain of varicella-zoster virus.水痘-带状疱疹病毒Oka疫苗株的分子分析。
J Infect Dis. 2008 Mar 1;197 Suppl 2:S45-8. doi: 10.1086/522122.
9
The safety profile of varicella vaccine: a 10-year review.水痘疫苗的安全性概况:十年回顾
J Infect Dis. 2008 Mar 1;197 Suppl 2:S165-9. doi: 10.1086/522125.
10
Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates.区分Oka疫苗与亲代Oka及其他水痘-带状疱疹病毒分离株的核苷酸序列。
J Infect Dis. 2000 Mar;181(3):1153-7. doi: 10.1086/315335.

引用本文的文献

1
Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial.一种用于水痘的皮肤和神经减毒活疫苗的安全性和免疫原性:一项随机、双盲、对照、剂量递增和年龄递减的1期临床试验。
Lancet Reg Health West Pac. 2023 Feb 18;34:100707. doi: 10.1016/j.lanwpc.2023.100707. eCollection 2023 May.
2
Deep sequencing of viral genomes provides insight into the evolution and pathogenesis of varicella zoster virus and its vaccine in humans.对病毒基因组进行深度测序可深入了解人类水痘带状疱疹病毒及其疫苗的进化和发病机制。
Mol Biol Evol. 2014 Feb;31(2):397-409. doi: 10.1093/molbev/mst210. Epub 2013 Oct 25.
3
Varicella zoster virus latency.
水痘带状疱疹病毒潜伏
Future Virol. 2011 Mar;6(3):341-355. doi: 10.2217/fvl.10.90.
4
Molecular analysis of varicella vaccines and varicella-zoster virus from vaccine-related skin lesions.水痘疫苗及来自疫苗相关皮肤损伤的水痘-带状疱疹病毒的分子分析。
Clin Vaccine Immunol. 2011 Jul;18(7):1058-66. doi: 10.1128/CVI.05021-11. Epub 2011 May 11.
5
Impact of varicella vaccine on varicella-zoster virus dynamics.水痘疫苗对水痘-带状疱疹病毒动力学的影响。
Clin Microbiol Rev. 2010 Jan;23(1):202-17. doi: 10.1128/CMR.00031-09.
6
A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses.一种用于在临床标本中鉴定和区分水痘-带状疱疹病毒和单纯疱疹病毒野生型及疫苗株的实时聚合酶链反应检测方法,并与临床诊断结果进行比较。
J Med Virol. 2009 Jul;81(7):1310-22. doi: 10.1002/jmv.21506.